Medical Communications

The latest monthly edition of Pharmafocus, the June 2020 issue, is available to read for free online now! The world remains …

Darren Taylor lives with a range of conditions including Dercum’s disease, cystic fibrosis, fibromyalgia with chronic fatigue, and Tietze syndrome, …

Trump continues to play a key role in the unfolding COVID-19 pandemic, with the US currently coping with the largest …

President Donald Trump has announced that Dr Moncef Slaoui, the former head of GlaxoSmithKline’s vaccine division, will head up Operation …

Michael Varney, industry veteran and Head of Research & Development at Genentech, has announced he is to leave the role …

Abbott’s 13-minute ID NOW COVID-19 testing kits have come under scrutiny after a study from New York University (NYU) revealed …

The US National Institutes of Health (NIH) said it is launching a clinical trial testing hydroxychloroquine in combination with azithromycin …

The NHS’s first data breakdown of underlying health conditions in COVID-19 fatalities has shown that 1 in 4 deaths in …

The news this week continues to be dominated by COVID-19 vaccines and treatments, with the NIAID announcing the launch of …

A research team at the Institut Pasteur Korea have identified a drug that appears to be more effective in treating …

Dr LaRee Tracy, a lecturer at San Diego State University and Director of Biostatistics at PHASTAR, led a team of …

“Every professional faces challenges. As a woman in industry, particularly in leadership, it adds another dimension to those challenges in …

The NHS has set out plans to step up its non-COVID-19 services over the next six weeks. A letter from …

Bristol Myers Squibb and Acceleron Pharma’s Reblozyl (luspatercept) has secured a positivr opinion from the European Medicines Agency’s Committee for Medicinal …

The coronavirus pandemic is likely to last as long as two years and will not be properly controlled until two-thirds …